Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

To understand the molecular basis for hemophilia B in patients with little or no circulating Factor IX antigen, a patient who had less than 0.2% circulating Factor IX antigen (Factor IXSeattle 2) was selected for analysis of his Factor IX gene. Genomic DNA fragments from the abnormal gene were clone...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	J Clin Invest
Principais autores:	Schach, B G, Yoshitake, S, Davie, E W
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Clinical Investigation 1987
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC442341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2821070/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI113155
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!